1KVUE Stock Overview

Operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. More details

1KVUE fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	3/6
Past Performance	1/6
Financial Health	2/6
Dividends	1/6

Rewards

Trading at 31% below our estimate of its fair value

Earnings are forecast to grow 16.7% per year

Risk Analysis

Shares are highly illiquid

Dividend of 3.47% is not well covered by earnings or free cash flows

Has a high level of debt

Large one-off items impacting financial results

+ 1 more risk

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Kenvue Inc. Competitors

Intercos

BIT:ICOS

€1.3b

Pharmanutra

BIT:PHN

€516.7m

Hindustan Unilever

NSEI:HINDUNILVR

₹5.5t

Beiersdorf

XTRA:BEI

€27.7b

Price History & Performance

Summary of share price highs, lows and changes for Kenvue
Historical stock prices
Current Share Price	US$20.73
52 Week High	US$0
52 Week Low	US$0
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	3.47%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	1KVUE	IT Personal Products	IT Market
7D	n/a	1.6%	3.3%
1Y	n/a	-3.7%	11.0%

Return vs Industry: Insufficient data to determine how 1KVUE performed against the Italian Personal Products industry.

Return vs Market: Insufficient data to determine how 1KVUE performed against the Italian Market.

Price Volatility

Is 1KVUE's price volatile compared to industry and market?
1KVUE volatility
1KVUE Average Weekly Movement	n/a
Personal Products Industry Average Movement	5.1%
Market Average Movement	5.3%
10% most volatile stocks in IT Market	8.6%
10% least volatile stocks in IT Market	3.3%

Stable Share Price: 1KVUE's share price has been volatile over the past 3 months compared to the Italian market.

Volatility Over Time: Insufficient data to determine 1KVUE's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2022	22,000	Thibaut Mongon	www.kenvue.com

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Kenvue Inc. Fundamentals Summary

How do Kenvue's earnings and revenue compare to its market cap?
1KVUE fundamental statistics
Market cap	€39.57b
Earnings (TTM)	€908.46m
Revenue (TTM)	€13.63b

44.0x

P/E Ratio

2.9x

P/S Ratio

Is 1KVUE overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1KVUE income statement (TTM)
Revenue	US$15.46b
Cost of Revenue	US$6.47b
Gross Profit	US$8.99b
Other Expenses	US$7.96b
Earnings	US$1.03b

Last Reported Earnings

Dec 29, 2024

Next Earnings Date

May 08, 2025

Earnings per share (EPS)	0.54
Gross Margin	58.14%
Net Profit Margin	6.66%
Debt/Equity Ratio	87.8%

How did 1KVUE perform over the long term?

See historical performance and comparison

Dividends

3.5%

Current Dividend Yield

151%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/30 08:37
End of Day Share Price	2025/04/30 00:00
Earnings	2024/12/29
Annual Earnings	2024/12/29

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kenvue Inc. is covered by 24 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Ishan Majumdar	Baptista Research
Lauren Lieberman	Barclays
Lauren Lieberman	Barclays